Cargando…
P1371: GRAFT-VERSUS-HOST DISEASE OFFERS NO GRAFT-VERSUS-LEUKEMIA ADVANTAGE IN PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA AFTER HAPLO-IDENTICAL STEM CELL TRANSPLANTATION WITH POST-TRANSPLANT CYCLOPHOSPHAMIDE
| Autores principales: | , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9430097/ http://dx.doi.org/10.1097/01.HS9.0000848344.37775.fa |
| _version_ | 1784779656133607424 |
|---|---|
| author | Shimoni, A. Peczynski, C. Labopin, M. Angelucci, E. Koc, Y. Arat, M. Tischer, J. Sica, S. Gülbas, Z. Socié, G. Blaise, D. Pioltelli, P. Ozdogu, H. Vydra, J. Ciceri, F. Nagler, A. Mohty, M. |
| author_facet | Shimoni, A. Peczynski, C. Labopin, M. Angelucci, E. Koc, Y. Arat, M. Tischer, J. Sica, S. Gülbas, Z. Socié, G. Blaise, D. Pioltelli, P. Ozdogu, H. Vydra, J. Ciceri, F. Nagler, A. Mohty, M. |
| author_sort | Shimoni, A. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9430097 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-94300972022-08-31 P1371: GRAFT-VERSUS-HOST DISEASE OFFERS NO GRAFT-VERSUS-LEUKEMIA ADVANTAGE IN PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA AFTER HAPLO-IDENTICAL STEM CELL TRANSPLANTATION WITH POST-TRANSPLANT CYCLOPHOSPHAMIDE Shimoni, A. Peczynski, C. Labopin, M. Angelucci, E. Koc, Y. Arat, M. Tischer, J. Sica, S. Gülbas, Z. Socié, G. Blaise, D. Pioltelli, P. Ozdogu, H. Vydra, J. Ciceri, F. Nagler, A. Mohty, M. Hemasphere Posters Lippincott Williams & Wilkins 2022-06-23 /pmc/articles/PMC9430097/ http://dx.doi.org/10.1097/01.HS9.0000848344.37775.fa Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Posters Shimoni, A. Peczynski, C. Labopin, M. Angelucci, E. Koc, Y. Arat, M. Tischer, J. Sica, S. Gülbas, Z. Socié, G. Blaise, D. Pioltelli, P. Ozdogu, H. Vydra, J. Ciceri, F. Nagler, A. Mohty, M. P1371: GRAFT-VERSUS-HOST DISEASE OFFERS NO GRAFT-VERSUS-LEUKEMIA ADVANTAGE IN PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA AFTER HAPLO-IDENTICAL STEM CELL TRANSPLANTATION WITH POST-TRANSPLANT CYCLOPHOSPHAMIDE |
| title | P1371: GRAFT-VERSUS-HOST DISEASE OFFERS NO GRAFT-VERSUS-LEUKEMIA ADVANTAGE IN PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA AFTER HAPLO-IDENTICAL STEM CELL TRANSPLANTATION WITH POST-TRANSPLANT CYCLOPHOSPHAMIDE |
| title_full | P1371: GRAFT-VERSUS-HOST DISEASE OFFERS NO GRAFT-VERSUS-LEUKEMIA ADVANTAGE IN PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA AFTER HAPLO-IDENTICAL STEM CELL TRANSPLANTATION WITH POST-TRANSPLANT CYCLOPHOSPHAMIDE |
| title_fullStr | P1371: GRAFT-VERSUS-HOST DISEASE OFFERS NO GRAFT-VERSUS-LEUKEMIA ADVANTAGE IN PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA AFTER HAPLO-IDENTICAL STEM CELL TRANSPLANTATION WITH POST-TRANSPLANT CYCLOPHOSPHAMIDE |
| title_full_unstemmed | P1371: GRAFT-VERSUS-HOST DISEASE OFFERS NO GRAFT-VERSUS-LEUKEMIA ADVANTAGE IN PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA AFTER HAPLO-IDENTICAL STEM CELL TRANSPLANTATION WITH POST-TRANSPLANT CYCLOPHOSPHAMIDE |
| title_short | P1371: GRAFT-VERSUS-HOST DISEASE OFFERS NO GRAFT-VERSUS-LEUKEMIA ADVANTAGE IN PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA AFTER HAPLO-IDENTICAL STEM CELL TRANSPLANTATION WITH POST-TRANSPLANT CYCLOPHOSPHAMIDE |
| title_sort | p1371: graft-versus-host disease offers no graft-versus-leukemia advantage in patients with acute lymphoblastic leukemia after haplo-identical stem cell transplantation with post-transplant cyclophosphamide |
| topic | Posters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9430097/ http://dx.doi.org/10.1097/01.HS9.0000848344.37775.fa |
| work_keys_str_mv | AT shimonia p1371graftversushostdiseaseoffersnograftversusleukemiaadvantageinpatientswithacutelymphoblasticleukemiaafterhaploidenticalstemcelltransplantationwithposttransplantcyclophosphamide AT peczynskic p1371graftversushostdiseaseoffersnograftversusleukemiaadvantageinpatientswithacutelymphoblasticleukemiaafterhaploidenticalstemcelltransplantationwithposttransplantcyclophosphamide AT labopinm p1371graftversushostdiseaseoffersnograftversusleukemiaadvantageinpatientswithacutelymphoblasticleukemiaafterhaploidenticalstemcelltransplantationwithposttransplantcyclophosphamide AT angeluccie p1371graftversushostdiseaseoffersnograftversusleukemiaadvantageinpatientswithacutelymphoblasticleukemiaafterhaploidenticalstemcelltransplantationwithposttransplantcyclophosphamide AT kocy p1371graftversushostdiseaseoffersnograftversusleukemiaadvantageinpatientswithacutelymphoblasticleukemiaafterhaploidenticalstemcelltransplantationwithposttransplantcyclophosphamide AT aratm p1371graftversushostdiseaseoffersnograftversusleukemiaadvantageinpatientswithacutelymphoblasticleukemiaafterhaploidenticalstemcelltransplantationwithposttransplantcyclophosphamide AT tischerj p1371graftversushostdiseaseoffersnograftversusleukemiaadvantageinpatientswithacutelymphoblasticleukemiaafterhaploidenticalstemcelltransplantationwithposttransplantcyclophosphamide AT sicas p1371graftversushostdiseaseoffersnograftversusleukemiaadvantageinpatientswithacutelymphoblasticleukemiaafterhaploidenticalstemcelltransplantationwithposttransplantcyclophosphamide AT gulbasz p1371graftversushostdiseaseoffersnograftversusleukemiaadvantageinpatientswithacutelymphoblasticleukemiaafterhaploidenticalstemcelltransplantationwithposttransplantcyclophosphamide AT socieg p1371graftversushostdiseaseoffersnograftversusleukemiaadvantageinpatientswithacutelymphoblasticleukemiaafterhaploidenticalstemcelltransplantationwithposttransplantcyclophosphamide AT blaised p1371graftversushostdiseaseoffersnograftversusleukemiaadvantageinpatientswithacutelymphoblasticleukemiaafterhaploidenticalstemcelltransplantationwithposttransplantcyclophosphamide AT pioltellip p1371graftversushostdiseaseoffersnograftversusleukemiaadvantageinpatientswithacutelymphoblasticleukemiaafterhaploidenticalstemcelltransplantationwithposttransplantcyclophosphamide AT ozdoguh p1371graftversushostdiseaseoffersnograftversusleukemiaadvantageinpatientswithacutelymphoblasticleukemiaafterhaploidenticalstemcelltransplantationwithposttransplantcyclophosphamide AT vydraj p1371graftversushostdiseaseoffersnograftversusleukemiaadvantageinpatientswithacutelymphoblasticleukemiaafterhaploidenticalstemcelltransplantationwithposttransplantcyclophosphamide AT cicerif p1371graftversushostdiseaseoffersnograftversusleukemiaadvantageinpatientswithacutelymphoblasticleukemiaafterhaploidenticalstemcelltransplantationwithposttransplantcyclophosphamide AT naglera p1371graftversushostdiseaseoffersnograftversusleukemiaadvantageinpatientswithacutelymphoblasticleukemiaafterhaploidenticalstemcelltransplantationwithposttransplantcyclophosphamide AT mohtym p1371graftversushostdiseaseoffersnograftversusleukemiaadvantageinpatientswithacutelymphoblasticleukemiaafterhaploidenticalstemcelltransplantationwithposttransplantcyclophosphamide |